Morning Market Losers
January 05, 2015 at 09:57 AM EST
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares dropped 24.76% to $5.64 after the company reported final analysis of Phase 2a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.